Sigachi Industries Ltd

Sigachi Indust. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Sigachi Industries Ltd

₹ 22.4 4.93%
01 Jun - close price
sigachi.com BSE: 543389 NSE: SIGACHI
About

Incorporated in 1989, Sigachi Industries Ltd is a manufacturing and selling of MCC.[1]

Key Points

Business Overview:[1][2][3]
SIL is one of the largest manufacturers of Cellulose based excipients. The company manufactures MCC in 60 distinct grades ranging from 15 microns to 250 microns. With over 60+ products, the company is in the business of:
a) Active Pharmaceutical Ingredients
b) Intermediates
c) Pharmaceutical Excipients
d) Vitamin-mineral blends
e) Polymer blends
f) Food & Nutrition
g) Operations and Management services

Website BSE NSE - BE
  • Market Cap ₹ 854 Cr.
  • Current Price ₹ 22.4
  • High / Low ₹ 59.6 / 16.6
  • Stock P/E 26.3
  • Book Value ₹ 13.6
  • Dividend Yield 0.45 %
  • ROCE 6.24 %
  • ROE 5.80 %
  • Face Value ₹ 1.00
Edit ratios

Pros

Cons

  • Promoter holding has decreased over last quarter: -3.01%
  • Tax rate seems low
  • Company has a low return on equity of 11.2% over last 3 years.
  • Promoters have pledged 27.7% of their holding.
  • Company has high debtors of 171 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
72.42 84.70 99.18 110.95 104.13 95.71 124.90 139.42 128.20 128.25 110.48 117.21 121.90
60.25 68.39 77.76 88.36 87.80 74.69 107.67 106.25 99.65 104.14 102.96 111.49 105.49
Operating Profit 12.17 16.31 21.42 22.59 16.33 21.02 17.23 33.17 28.55 24.11 7.52 5.72 16.41
OPM % 16.80% 19.26% 21.60% 20.36% 15.68% 21.96% 13.80% 23.79% 22.27% 18.80% 6.81% 4.88% 13.46%
1.55 1.63 1.11 1.71 7.24 1.68 14.64 2.02 2.19 -117.07 7.15 -0.26 0.21
Interest 1.41 1.27 1.79 1.84 2.87 3.16 2.10 3.82 3.33 3.31 3.13 3.13 4.33
Depreciation 1.98 1.96 2.52 2.82 3.49 3.15 3.22 4.67 4.74 4.72 4.11 4.18 4.57
Profit before tax 10.33 14.71 18.22 19.64 17.21 16.39 26.55 26.70 22.67 -100.99 7.43 -1.85 7.72
Tax % 29.24% 26.04% 17.01% 18.02% 11.85% 22.21% 20.83% 23.22% 28.67% -0.02% -41.59% -98.92% 0.78%
7.32 10.88 15.12 16.10 15.17 12.76 21.01 20.51 16.18 -100.97 10.53 -0.01 7.65
EPS in Rs 0.24 0.35 0.49 0.50 0.46 0.40 0.65 0.64 0.35 -2.63 0.28 0.01 0.20
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
101 129 139 193 250 302 399 488 478
89 103 114 154 197 243 322 388 424
Operating Profit 12 26 25 39 53 59 77 100 54
OPM % 12% 20% 18% 20% 21% 19% 19% 20% 11%
3 4 5 3 3 7 12 21 -110
Interest 4 3 2 1 1 4 8 12 14
Depreciation 1 2 2 2 3 7 11 16 18
Profit before tax 10 25 25 38 52 54 70 92 -88
Tax % 28% 23% 20% 21% 22% 20% 18% 24% -6%
7 19 20 30 40 44 57 70 -83
EPS in Rs 2.25 6.19 2.65 3.94 1.30 0.00 1.74 1.82 -2.14
Dividend Payout % 4% 2% 4% 0% 8% 6% 5% 0%
Compounded Sales Growth
10 Years: %
5 Years: 20%
3 Years: 17%
TTM: -2%
Compounded Profit Growth
10 Years: %
5 Years: 1%
3 Years: %
TTM: -53%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -3%
1 Year: -58%
Return on Equity
10 Years: %
5 Years: 11%
3 Years: 11%
Last Year: 6%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 3 3 8 8 31 31 33 38 38
Reserves 23 42 57 87 197 238 397 563 484
30 25 30 21 35 68 151 142 139
16 21 14 18 24 37 113 103 180
Total Liabilities 72 91 109 133 287 374 694 846 841
26 29 32 38 53 122 254 370 325
CWIP 1 2 3 4 10 35 97 9 31
Investments 0 0 0 0 0 0 0 0 0
46 61 74 92 224 216 342 467 485
Total Assets 72 91 109 133 287 374 694 846 841

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
8 14 12 30 6 29 13 27
-4 -6 -7 -11 -63 -92 -161 -93
-5 -9 3 -11 108 26 172 81
Net Cash Flow -1 -0 8 7 51 -37 24 15
Free Cash Flow 3 9 6 20 -18 -72 -72 -16
CFO/OP 88% 75% 69% 94% 33% 71% 29% 41%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 77 70 72 68 88 97 137 137 171
Inventory Days 99 123 141 77 94 123 132 155 108
Days Payable 52 48 37 29 33 55 90 59 87
Cash Conversion Cycle 124 145 177 116 149 165 180 234 193
Working Capital Days 7 43 59 70 86 85 63 103 71
ROCE % 44% 34% 38% 28% 20% 17% 16% 6%

Insights

In beta
Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Actual MCC Production Volume
MT

Log in to view insights

Please log in to see hidden values.

Login
Total Installed MCC Capacity
MTPA
Export Share in Revenue
%
Global Presence (Countries)
Count
Overall MCC Capacity Utilization
%
Product Portfolio (SKU)
Count
Average Realization - MCC
Rs/Kg
R&D Expenditure (Percentage of Turnover)
% ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
48.49% 48.49% 46.08% 45.43% 45.43% 44.71% 44.71% 44.14% 44.14% 40.48% 39.70% 36.69%
0.05% 0.95% 1.76% 2.06% 1.55% 1.58% 0.16% 0.08% 2.89% 3.10% 3.33% 1.31%
51.45% 50.56% 52.17% 52.51% 53.01% 53.69% 55.12% 55.77% 52.97% 56.41% 56.97% 62.01%
No. of Shareholders 84,57479,86297,0531,37,5061,37,1931,52,0461,56,3981,60,5611,51,2062,05,2661,94,7771,94,559

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls